BAX

47 Ways to End Earnings Season On A High Note

Earnings season may be wrapping up in the next few weeks, but the last push is going to be an important one. Get a first look with our updated portfolio ratings More 

Facebook Makes the Grade and Is Now a Buy

Yes, you read that correctly. After spending months in sell territory, Facebook has made a complete turnaround in a matter of days and is now a buy More 

Energy Amps Up the Payouts: 17 Companies Increasing Dividends

Energy XXI made one of this week's most aggressive moves among companies sweetening the dividend pot. Here's a look at EXXI and the 16 other improved payouts. More 

Baxter’s Alzheimer’s Drug Fails in Study

A drug from Baxter International aimed at reducing mental decline in Alzheimer's patients failed to show improvement compared to a placebo in a clinical trial. More 

4 Call Contenders: Healthcare

Watch these healthcare names for a continued steady climb upward--and consider profiting with call options. More 

Top 6 Stocks to Buy for April

Health care and tech stocks, including Apple (NASDAQ:AAPL), top this month's list of stocks to buy. More 

Sector Scan: Hospital Supply

Healthcare stocks are booming. Find out which ones are liquid and volatile enough to make a trade or options play worthwhile. More